Yotta Acquisition Corp. (NASDAQ:YOTA) entered into non-redemption agreements with certain unaffiliated third parties in exchange for such third parties agreeing not to redeem an aggregate of 598,680 shares of the Company’s common stock. ...READ MORE
Twin Ridge (NYSE:TRCA) announced this afternoon that it plans to convene and then adjourn its extraordinary general meeting of its shareholders originally to be held on September 26 at 11:30 a.m., ...READ MORE
Social Leverage Acquisition Corp I (Nasdaq: SLAC) and W3BCLOUD Holdings Inc. announced this afternoon that they have mutually agreed to terminate their business combination agreement.
The reasons cited were once again “due to existing market conditions”, which most likely implies the current capital market conditions as well as the fact that W3BCLOUD works within the blockchain sector. ...READ MORE
Graf Acquisition Corp. IV (NYSE:GFOR) announced that it adjourned Wednesday’s completion vote for its combination with NKGen Biotech without conducting any business and will reopen proceedings at 4:00 p.m., Eastern time, on September 25, 2023
Once again, the adjournment is being done to provide additional time to continue its efforts to obtain additional financing. ...READ MORE
26 Capital Acquisition Corp. (Nasdaq: ADER), today announced that it will be unable to complete an initial business combination within the time period required due to the Delaware Court of Chancery’s decision denying 26 Capital’s request for an order of specific performance in an action commenced in February 2022 against certain of the parties (the “UEC Parties”) to the Merger and Share Acquisition Agreement. ...READ MORE
Murphy Canyon Acquisition Corp. (NASDAQ:MURF) announced this afternoon that its stockholders voted in favor of the proposed business combination with Conduit Pharmaceuticals Limited (“Conduit”).
Details on the vote, along with redemption numbers, have not been filed yet, but the Company expects the closing to occur as soon as practicable, subject to the satisfaction or waiver of remaining closing conditions. ...READ MORE
Juniper II Corp. (NYSE: JUN), today announced that its board of directors has determined to redeem all of its outstanding shares of Class A common stock with such redemption anticipated to be effective as of October 10, 2023. ...READ MORE
TradeUP (NASDAQ:UPTD) announced in an 8-K this afternoon that has entered into additional subscription agreements in connection with its combination with Estrella Biopharma.
Under these subscription agreements, Plentiful Limited and Lianhe World Limited, collectively known as the “Investors”, agreed to each buy $5,000,000 worth of UPTD’s common stock, priced at $10.00 per share. ...READ MORE
Blockchain Coinvestors I (NASDAQ:BCSA) announced this afternoon that it is postponing its special meeting to extend its timeline to complete its business combination.
The meeting was originally scheduled to be held on September 22, but will now be moved to Friday, October 27, 2023, at 11:30 a.m. ...READ MORE
Graf Acquisition Corp. IV (NYSE:GFOR) announced in an 8-K this afternoon that it has entered into a warrant subscription agreement with certain unnamed investors ahead of its completion vote to combine with NKGen Biotech. ...READ MORE
Kingswood (OTC Pink:KWAC) announced via 8-K this afternoon that they have entered into their Second Amendment to the merger with broker-dealer aggregator Wentworth Management Services LLC.
This combination was originally announced over a year ago in July of 2022, with a pro forma enterprise value of $208 million. ...READ MORE
Global Partner Acquisition Corp II (Nasdaq: GPAC), today announced that its board of directors has determined not to extend the date by which the Company must complete its initial business combination by an additional month. ...READ MORE
Sagaliam (NASDAQ:SAGA), which previously announced it had signed a non-binding letter of intent (LOI) for the purchase of Biogenysis, Inc. and Virogentics Inc., operating subsidiaries of Enzolytics Inc. (OTC Pink: ENZC), announced this afternoon that it has now executed a definitive business combination agreement. ...READ MORE
Biotech firms tend to come on to SPACs’ radar when they still have some clinical work to complete to get to an approved medicine or device, but Avertix is ahead of that particular curve. ...READ MORE
Sustainable materials are starting to take a bite out of the share of single-use plastics in circulation, but replacing the full $600 billion plastics market is going to take more innovation and much more capital. ...READ MORE